What is the recommendation for primary stroke prevention in asymptomatic patients with a hereditary or acquired thrombophilia?
The usefulness of specific treatments for primary stroke prevention in asymptomatic patients with a hereditary or acquired thrombophilia is not well established (Class IIb; Level of Evidence C).